chevron_leftBack
S
As of 13 June 2026, Sai Parenteral's Ltd. has a market cap of $225.6M USD, ranking #20329 globally and #1150 in India.
It ranks #1825 in the Healthcare sector, and #663 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$225.6MUSD
21.51B INR
Enterprise Value
$232.16MUSD
22.14B INR
Revenue (TTM)
$17.1MUSD
1.63B INR
EBITDA (TTM)
$4.18MUSD
399.07M INR
Net Income (TTM)
$1.52MUSD
144.54M INR
EBITDA Margin
24%
Profit Margin
8.9%
PE Ratio
89.8
PS Ratio
13.2
PB Ratio
22.5
EV/EBITDA
55.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
D. B. Prakash
open_in_new
Employees
296
Founded
1988
Website
saiparenterals.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.9% | -0.7% | 20% | 42% | 42% | 42% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SAIPARENT
ISIN: INE0H9F01037
Shares Out.:
Shares Outstanding:
44.179M1
Shares Float:
8.196M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
486.95 INR | |
|
SAIPARENT
ISIN: INE0H9F01037
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
513.20 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sai Parenteral's Ltd.
Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company was founded in 1988 and is based in Hyderabad, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$44.75B
20K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.19B
8K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.01B
7K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.61B
5K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.77B
4K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.61B
4K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
338K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
242K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
160K%
|
97.4
|
|
SIX: RO
|
$321.52B
142K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
128K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
122K%
218.9B CHF
|
20.5
|
chevron_leftBack